Extraosseous Extension: Definition

Print this article

Extraosseous extension means that a tumor that started inside a bone has grown out through the hard outer layer of the bone into the soft tissue around it. “Extra” means outside, and “osseous” means bone. The soft tissue around a bone includes muscle, fat, tendons, and the tissue around joints. Your report may also describe this as “soft tissue extension” or “extension beyond the bone.”

Extraosseous extension describes how far a tumor has grown, not a diagnosis on its own. It is most often reported for cancers of the bone, but it can also be seen in some noncancerous bone tumors. This article explains what extraosseous extension means, how it is identified, and why it matters in your pathology report.

How does a tumor grow outside the bone?

A bone has a hard outer shell called the cortex. Inside the cortex is softer, spongy bone and bone marrow. Many bone tumors start inside the bone and grow outward. As the tumor gets larger, it can wear away or break through the cortex and push into the tissue around the bone.

A thin membrane called the periosteum covers the bone. A tumor may lift this membrane as it grows. Once the tumor grows past the cortex and the periosteum into the surrounding soft tissue, extraosseous extension is present.

Which tumors can show extraosseous extension?

Extraosseous extension is most common in tumors that grow quickly or have been present for a long time. Examples include:

Bone sarcomas. Bone cancers such as osteosarcoma, Ewing sarcoma, and higher-grade chondrosarcoma often grow into the soft tissue. In Ewing sarcoma, the part of the tumor outside the bone can be larger than the part inside it.
Plasma cell tumors and cancer that has spread to bone. A plasmacytoma or cancer that has spread to bone from another organ can break through the cortex.
Some noncancerous tumors. A giant cell tumor of bone or an aneurysmal bone cyst can thin and expand the bone, and sometimes extends into nearby soft tissue. In these tumors, extraosseous extension does not mean the tumor is cancer.

In a cartilage tumor, growth through the cortex into soft tissue is one feature that helps separate a chondrosarcoma from a noncancerous enchondroma.

How is extraosseous extension identified?

Extraosseous extension is usually seen first on imaging. An MRI or CT scan shows whether the tumor has broken through the bone and how far it reaches into the surrounding tissue. These images help the surgeon plan how much tissue to remove.

When the tumor is removed, the pathologist examines the bone and surrounding soft tissue, first with the naked eye and then under the microscope. Your report may say whether extraosseous extension is “present” or “absent” and describe which tissues the tumor reached. A small biopsy often cannot show extraosseous extension, so this information usually comes from imaging or from the surgical specimen.

Why is extraosseous extension important?

Extraosseous extension is important for several reasons:

Staging. For pelvic bone cancers, extraosseous extension is part of the tumor stage. It is one feature used to assign the pT category in the American Joint Committee on Cancer (AJCC) staging system, 8th edition. For bone cancers in the arms, legs, and trunk, the pT category is based mainly on size instead.
Surgery. When a tumor has grown into the soft tissue, the surgeon must remove that tissue as well as the bone. Your report will describe whether the tumor reaches the margins (the edges of the removed tissue).
Diagnosis. In some tumors, such as cartilage tumors, growth into soft tissue supports a diagnosis of cancer rather than a noncancerous tumor.

The meaning of extraosseous extension depends on the tumor type. Your doctor will consider it along with the diagnosis, grade, tumor size, and margins.

Questions to ask your doctor

Did my tumor grow outside the bone?
Which tissues did the tumor reach?
Does extraosseous extension change the stage of my tumor?
Were the margins free of tumor, including in the soft tissue?
Was extraosseous extension seen on my imaging, in the surgical specimen, or both?
Does this finding change my treatment plan?
Do I need any further imaging or follow-up?